T. Müller

Evaluation of Sentinel Lymph Node Biopsy and Axillary Lymph Node Dissection for Breast Cancer Treatment Concepts - a Retrospective Study of 1,214 Breast Cancer Patients

S. Blasius, S. Häusler, J. Diessner, 2017, Breast Care.

Heat shock protein 27 is associated with decreased survival in node-negative breast cancer patients.

M. Sütterlin, J. Dietl, A. Gassel, 2005, Anticancer research.

Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinoma

H. Caffier, A. Gassel, T. Müller, 2006, Archives of Gynecology and Obstetrics.

[Ovarian epidermoid cyst and endometrioid carcinoma: do they share their origin?].

J. Dietl, A. Gassel, T. Müller, 2002, Zentralblatt fur Gynakologie.

Galactography and Exfoliative Cytology in Women With Abnormal Nipple Discharge

M. Rominger, H. Dinkel, A Tschammler, 2001, Obstetrics and gynecology.

Predictive value of galactographic patterns for benign and malignant neoplasms of the breast in patients with nipple discharge.

M. Rominger, H. Dinkel, A Tschammler, 2000, The British journal of radiology.

Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity—a retrospective study of 1214 breast cancer patients

S. Blasius, R. Stein, A. Wöckel, 2018, Archives of Gynecology and Obstetrics.

Heat-shock protein 70 as a prognostic marker in node-negative breast cancer.

M. Sütterlin, J. Dietl, A. Gassel, 2003, Anticancer research.

[Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].

S. Schön, A. Gassel, T. Müller, 1997, Zentralblatt für Gynäkologie.

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

M. Rezai, T. Fehm, T. Kühn, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.